202161
PR Heartseed and Novo Nordisk enter into global collaboration and licence agreement for stem cell-based therapy for heart failure
2021323
PR Heartseed Initiates Ph1/2 Clinical Trial of iPSC-derived Cardiomyocyte Spheroids (LAPiS Study) in Japan
202131
PR Heartseed named "Minister of Science and Technology Policy Award" at Japan Venture Awards 2021
2018918
PR Heartseed Inc. was selected as one of the subsidy program of Japan Agency for Medical Research and Development (AMED), supporting Research Project for Practical Applications of Regenerative Medicine